Johannes-Peter Haas Selected Research

Johannes-Peter Haas Research Topics

Disease

18	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2022 - 01/2014
6	Arthritis (Polyarthritis) 01/2021 - 01/2013
5	Uveitis 11/2021 - 05/2016
2	Myositis (Idiopathic Inflammatory Myopathies) 02/2022 - 09/2016
2	Dermatomyositis (Dermatopolymyositis) 02/2022 - 09/2016
2	Muscle Weakness 02/2022 - 06/2018
2	Inflammation (Inflammations) 01/2018 - 12/2010
2	Rheumatoid Arthritis 01/2018 - 12/2005
1	Disease Progression 01/2020
1	Calcinosis 06/2018
1	Tuberculosis (Tuberculoses) 03/2018
1	Chickenpox 03/2018
1	Exanthema (Rash) 03/2018
1	Rheumatic Diseases (Rheumatism) 03/2018
1	Fever (Fevers) 01/2018
1	Disease Susceptibility (Diathesis) 01/2018
1	Familial Mediterranean Fever (Periodic Disease) 12/2016
1	Headache (Headaches) 09/2016
1	Nausea 09/2016
1	Vomiting 09/2016
1	Neoplasms (Cancer) 02/2016
1	Negative rheumatoid factor polyarthritis 12/2015
1	Hearing Loss (Hearing Impairment) 12/2010
1	Cryopyrin-Associated Periodic Syndromes 12/2010
1	Musculoskeletal Diseases (Musculoskeletal Disease) 12/2010
1	Central Nervous System Vasculitis 07/2002
1	Neurologic Manifestations (Neurological Manifestations) 07/2002
1	Vasculitis (Vasculitides) 07/2002

Drug/Important Bio-Agent (IBA)

5	Biological ProductsIBA 01/2021 - 01/2013
5	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 02/2016
4	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2013
4	SteroidsIBA 09/2016 - 07/2002
3	CytokinesIBA 04/2022 - 12/2010
3	Interleukin-1 (Interleukin 1)IBA 03/2021 - 12/2010
3	Etanercept (Enbrel)FDA Link 01/2021 - 05/2016
2	C-Reactive ProteinIBA 11/2021 - 01/2018
2	GlucocorticoidsIBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 02/2016
2	EnzymesIBA 06/2018 - 09/2016
2	Immunoglobulin G (IgG)IBA 03/2018 - 09/2016
2	Rheumatoid FactorIBA 01/2018 - 01/2014
2	Adalimumab (Humira)FDA Link 11/2016 - 05/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2022
1	AutoantibodiesIBA 02/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	hydroxide ionIBA 12/2018
1	Vitamin D FDA LinkGeneric 12/2018
1	Immunoglobulin M (IgM)IBA 03/2018
1	Interferon-gamma (Interferon, gamma)IBA 03/2018
1	MitogensIBA 03/2018
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 03/2018
1	VaccinesIBA 03/2018
1	InterleukinsIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018
1	PyrinIBA 12/2016
1	tocilizumab (atlizumab)FDA Link 11/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2016
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 09/2016
1	Immunoglobulins (Immunoglobulin)IBA 09/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2015
1	Interleukin-12 Subunit p40IBA 12/2015
1	Antinuclear AntibodiesIBA 01/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2013
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2013
1	Hemoglobins (Hemoglobin)IBA 12/2010
1	amsonic acid (DAS)IBA 12/2010
1	ChemokinesIBA 12/2005
1	Messenger RNA (mRNA)IBA 12/2005
1	AntibodiesIBA 07/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2002

Therapy/Procedure

7	Therapeutics 01/2021 - 07/2002